MUC1 and cancer: Aptamer-based optical biosensors utilizing colorimetric and fluorescent responses have demonstrated significant potential for detecting MUC1, a critical cancer biomarker, by integrating the specific recognition capabilities of aptamers with visually or spectroscopically detectable signals.